Neuromyelitis Optica.

Area of Science:

• Neuroimmunology
• Autoimmune Neurology
• Demyelinating Diseases

Background:

• Neuromyelitis optica (NMO), also known as Devic disease, is a severe autoimmune astrocytopathic condition.
• It is characterized by recurrent episodes of optic neuritis and transverse myelitis, often leading to significant disability.
• The disease primarily targets astrocytes expressing aquaporin-4 water channels.

Purpose of the Study:

• To outline the key features of Neuromyelitis optica (NMO).
• To describe the underlying pathogenesis, diagnostic criteria, and current treatment strategies for NMO.

Main Methods:

• Review of current understanding of NMO pathogenesis.
• Summary of diagnostic approaches including clinical, serological (AQP4-IgG), and neuroimaging findings.
• Overview of established treatment protocols for acute attacks and long-term management.

Main Results:

• NMO pathogenesis involves AQP4-IgG production, leading to blood-brain barrier disruption and astrocyte injury.
• Diagnosis requires characteristic clinical events, positive AQP4-IgG serology or specific imaging, and exclusion of other conditions.
• Relapsing courses are common, with incomplete recovery contributing to progressive neurological deficits.

Conclusions:

• Effective management of NMO necessitates aggressive immunosuppressive therapies.
• Treatment includes high-dose steroids for acute relapses and maintenance immunosuppression to prevent future attacks.
• Understanding NMO's autoimmune basis is crucial for developing targeted therapies.